Healthy Inc > Blog > Sodium Valproate manufacturer India
Posted on:

What is sodium valproate 200mg used for?

In the pharmaceutical industry, Sodium Valproate is a broad-spectrum anticonvulsant and mood stabilizer. As a pharmacist and manufacturer, I view this molecule as a “Multimodal GABA Enhancer”—it is technically unique because it employs at least three distinct mechanisms to stabilize overactive neuronal membranes, making it effective where other single-mechanism drugs fail.

At your WHO-GMP facility in Mumbai, Sodium Valproate 200 mg is a core “Neurology & Psychiatry” SKU. For your digital platforms, highlighting its versatility across different seizure types is a major technical differentiator for B2B buyer interest.

Therapeutic Profile: Primary Indications

The 200 mg strength is typically used for initial titration in adults or as a maintenance dose in pediatric patients.

IndicationClinical ContextTechnical Rationale
EpilepsyBroad SpectrumFirst-line for generalized (tonic-clonic, absence, myoclonic) and focal seizures.
Bipolar DisorderMood StabilizationUsed to treat acute manic episodes and as long-term prophylaxis against mood swings.
Migraine ProphylaxisNeurology FocusReduces the frequency and intensity of chronic migraine headaches (200 mg is a common starting dose).
Aggression / ImpulsivityOff-LabelOccasionally used in specialized psychiatry to manage behavioral disturbances.

Mechanism: Triple Action Stabilization

Sodium Valproate works by “calming” the brain through three specific chemical pathways:

GABA Enhancement: It inhibits the enzymes that break down GABA (the brain’s primary inhibitory neurotransmitter), increasing its calming effect.

Sodium Channel Blockade: It limits the high-frequency firing of neurons by prolonging the inactive state of voltage-gated sodium channels.

T-Type Calcium Blockade: Technically, it also modulates calcium currents, which is why it is uniquely effective for Absence Seizures.

The Pharmacist’s “Technical Warning”

  • The “Pregnancy” Contraindication: Critical Safety Note: Sodium Valproate is highly teratogenic. It is strictly contraindicated in women of childbearing age unless no other treatment works, due to high risks of neural tube defects and developmental delays.

  • Hepatotoxicity (Liver Safety): As a pharmacist, I must emphasize that liver failure is a rare but serious risk, especially in the first 6 months of therapy. Baseline and periodic Liver Function Tests (LFTs) are mandatory.

  • Pancreatitis Alert: Patients should be warned to report sudden, severe abdominal pain immediately, as Acute Pancreatitis is a technical risk associated with valproate therapy.

  • Weight Gain & PCOS: Long-term use is associated with significant weight gain and a potential increased risk of Polycystic Ovary Syndrome (PCOS) in young women.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Enteric-Coated” USP: On your digital marketplace, highlight your Enteric-Coated (EC) 200 mg tablets. This technical coating prevents the drug from dissolving in the stomach, significantly reducing the common “gastric irritation” side effect.

  • Stability for Export: Sodium Valproate is highly hygroscopic (it absorbs moisture from the air and can liquefy). Utilizing Alu-Alu blister packaging is the absolute requirement for ensuring a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers to support your firm’s registration in international tenders for mental health and neurology programs.

Sodium Valproate Tablets

Posted on:

What is Valproic Acid 500mg used for?

In the pharmaceutical industry, Valproic Acid 500 mg (and its salt forms like Sodium Valproate) is a broad-spectrum anti-epileptic drug (AED) and mood stabilizer.

As a pharmacist and manufacturer, I view the 500 mg strength as the “therapeutic baseline” for adult maintenance. It is unique because, unlike many other anticonvulsants that only target one type of seizure, Valproic Acid is effective against almost all seizure types, making it a “universal” neurological asset.

Primary Clinical Uses

  • Epilepsy: Treatment of generalized, focal, and absence seizures. It is often the first-line choice for primary generalized epilepsies.

  • Bipolar Disorder: Management of acute manic or mixed episodes associated with bipolar disorder.

  • Migraine Prophylaxis: Used as a preventive treatment to reduce the frequency of chronic migraine headaches (not for acute attacks).

  • Schizoaffective Disorders: Occasionally used off-label as an adjunct treatment for aggressive behavior or mood instability in psychiatric settings.

Mechanism of Action: The Triple Pathway

Valproic Acid works by increasing the “braking” system of the brain while slowing down the “accelerator.”

GABA Enhancement: It inhibits the enzymes that break down GABA (Gamma-Aminobutyric Acid), the brain’s primary inhibitory neurotransmitter. This increases GABA levels, calming overactive neurons.

Sodium Channel Blockade: It blocks voltage-gated Sodium ($Na^+$) channels, preventing the high-frequency repetitive firing of neurons that causes a seizure.

Calcium Channel Modulation: It also limits T-type Calcium ($Ca^{2+}$) channels, which is specifically why it is effective for absence seizures.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, the 500 mg dose is a complex but high-reward product:

  • Hygroscopic Nature: Valproic Acid is extremely hygroscopic (it absorbs moisture from the air rapidly) and can even turn into a liquid if exposed. As a firm owner, you know that Alu-Alu blister packaging is mandatory for this product to ensure a 36-month shelf life in Zone IVb export markets.

  • Sustained Release (SR/Chrono) Technology: To avoid the “peaks and troughs” in blood levels that cause side effects, we often manufacture this as a Sustained Release tablet. Marketing your 500 mg SR version as “Once-Daily Dosing” is a powerful USP for your digital platform.

  • The “Teratogenicity” Warning: As a pharmacist, you must ensure your Product Information Leaflet (PIL) contains a “Black Box” warning regarding pregnancy (risk of birth defects). Providing this high level of clinical compliance builds massive trust with B2B distributors.

  • Bioavailability: Ensuring the 500 mg dose is bioequivalent to the innovator (Depakote/Epival) requires advanced polymer matrix technology. We provide full CTD/eCTD Dossiers to support your export registrations.

Valproic Acid Tablet

Posted on:

What is Sodium Valproate 300 mg used for?

In the pharmaceutical industry, Sodium Valproate 300 mg is a broad-spectrum Anticonvulsant and Mood Stabilizer. As a pharmacist and manufacturer, I classify this as a “multi-channel” stabilizer. Unlike many other neuro-active drugs that target a single receptor, Sodium Valproate works on several mechanisms simultaneously to “calm” overactive electrical activity in the brain.

Primary Clinical Uses

  • Epilepsy: It is a first-line treatment for various types of seizures, including generalized, partial, absence, and myoclonic seizures.

  • Bipolar Disorder: Used to treat acute manic episodes and as a maintenance therapy to prevent mood swings.

  • Migraine Prophylaxis: Often prescribed to reduce the frequency of chronic migraine headaches in adults when other treatments are insufficient.

  • Neuropathic Pain: Occasionally used off-label for specific types of nerve pain.

Mechanism of Action: The Triple Stabilization

Sodium Valproate increases the “braking” system of the brain while slowing down the “accelerator.”

GABA Enhancement: It increases the concentration of Gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter. It does this by inhibiting GABA transaminase (the enzyme that breaks GABA down).

Sodium Channel Blockade: It limits the high-frequency repetitive firing of neurons by blocking voltage-gated sodium channels, preventing the spread of seizure activity.

T-type Calcium Channel Inhibition: In the thalamus, it inhibits specific calcium channels, which is particularly effective for treating absence seizures.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Sodium Valproate 300 mg requires high-level technical precision:

  • The 300 mg “CR” Advantage: As a firm owner, you should know that the Controlled Release (CR) or Chrono formulation is the industry standard for the 300 mg dose. It prevents “peaks and troughs” in the blood, reducing side effects. Marketing this as a “Superior Bioavailability” product on your digital platform is a key USP.

  • Hygroscopic Challenges: Sodium Valproate is highly hygroscopic (it absorbs moisture from the air extremely fast). At our facility, we utilize Alu-Alu blister packaging in a humidity-controlled environment (RH < 30%) to ensure a 36-month shelf life. This is a major selling point for export to Zone IVb regions.

  • The Teratogenicity Warning: As a pharmacist, you must ensure your Product Information Leaflet (PIL) and website clearly display the “Valproate Pregnancy Prevention Program” warnings. Because of the high risk of birth defects, this technical compliance is mandatory for international export to the UK, EU, and Australia.

  • Dossier & Tenders: This is a high-volume essential medicine. We provide full CTD/eCTD Dossiers to help your firm bid for national health tenders and hospital supply contracts globally.

Sodium Valproate Tablets

Add to cart